You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion Statement on the novel Coronavirus

read more 

EVENTS

Kedrion alongside IPOPI at the IPIC Congress in Madrid

The importance of early diagnosis and the most recent innovations in the treatment of PID patients were the focus

read more 

EVENTS

Kedrion keeps Hemophilia therapy debate flowing in Latin America

A recent CLAHT Congress symposium restates current and future role of replacement therapy

read more 

  1. CORPORATE - 25-08-2017

    Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®

    The product is approved for post-exposure prophylaxis against rabies infection

    read more 

  2. EVENTS - 14-07-2017

    Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany

    A crowded symposium dedicated to the SIPPET Study was held on July 9th

    read more 

  3. EVENTS - 22-05-2017

    Farmindustria roadshow is hosted by Kedrion

    Innovation and Production of Value held on 19th May at our Bolognana production plant

    read more 

  4. EVENTS - 27-04-2017

    Kedrion Biopharma joins IPOPI in celebrating World PI Week 2017

    Global campaign to improve early diagnosis and optimal treatments for PID

    read more 

Pages

For more information please contact: pressoffice@kedrion.com